Stocks · Health care · Pharmaceutical Preparations

Fulcrum Therapeutics, Inc.

FULC Clue Score33
United States Fiscal year ends December CIK 0001680581 Results filed 27 Apr 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Alex Sapir
3 Jul 2024
See Remarks
Exercised, kept
150,000
$3.27
$490.50K
Owen B. Wallace
14 Sep 2020
Chief Scientific Officer
Exercised, kept
6,350
$7.84
$49.78K

What was left out

Form 4 filings counted 183
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 28
Sales at will 41
Transactions with no price 0
Shares from compensation/vesting 32,104,196
Sales filed before the plan box existed 29
History held since 18 Jul 2019